EBS

시간 외 거래: 8.85 -0.11 -1.23%

Emergent Biosolutions Inc (EBS)

개요 뉴스 가격 이력 옵션 체인 토론 예측

Relative Volume:

Emergent Biosolutions Inc Stock (EBS) Company Profile

Emergent Biosolutions Inc

Healthcare (1181)

240-631-3200

400 PROFESSIONAL DR, SUITE 400, GAITHERSBURG, MD

@emergentbiosolu

최신 SEC 제출 서류

EBS's Discussions on Twitter

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-04-10	업그레이드	The Benchmark Company	Hold → Buy
2023-03-17	다운그레이드	JP Morgan	Neutral → Underweight
2022-11-10	다운그레이드	The Benchmark Company	Buy → Hold
2022-04-29	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2022-01-20	업그레이드	The Benchmark Company	Hold → Buy
2021-11-08	다운그레이드	The Benchmark Company	Buy → Hold
2021-05-05	다운그레이드	Argus	Buy → Hold
2021-04-07	개시	The Benchmark Company	Buy
2021-02-24	업그레이드	Chardan Capital Markets	Neutral → Buy
2021-02-19	다운그레이드	Chardan Capital Markets	Buy → Neutral
2021-01-08	다운그레이드	Wells Fargo	Overweight → Equal Weight
2020-09-14	재개	JP Morgan	Neutral
2020-07-31	재확인	Chardan Capital Markets	Buy
2019-09-12	개시	Guggenheim	Buy
2019-09-04	업그레이드	Wells Fargo	Market Perform → Outperform
2018-11-02	업그레이드	Goldman	Neutral → Buy
2018-08-03	재확인	Chardan Capital Markets	Buy
2018-06-13	개시	Argus	Buy
2018-04-25	다운그레이드	Wells Fargo	Outperform → Market Perform
2018-01-24	개시	Goldman	Neutral
2018-01-16	재확인	Chardan Capital Markets	Buy
2016-06-28	재확인	Singular Research	Buy
2016-04-15	개시	Chardan Capital Markets	Buy
2016-03-28	개시	Singular Research	Buy
2016-02-19	개시	Wells Fargo	Outperform
2014-05-15	개시	Summer Street Research	Buy
2011-05-31	재확인	WBB Securities	Strong Buy
2011-01-10	재확인	Wedbush	Outperform
2010-11-05	재확인	Wedbush	Outperform
2010-08-18	업그레이드	WBB Securities	Buy → Strong Buy
2010-08-06	재확인	Caris & Company	Buy

Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스

Emergent Biosolutions Inc (EBS) 재무 분석

Emergent Biosolutions Inc (EBS)

Emergent Biosolutions Inc Stock (EBS) Company Profile

Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades

Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스

Biotech Co. Emergent Gives Interim GC Permanent Role - Law360

Emergent BioSolutions appoints new chief medical officer - Investing.com

Emergent BioSolutions (EBS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat

Emergent Bio's smallpox vaccine gets US approval for mpox - AOL

Assenagon Asset Management S.A. Increases Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - Simply Wall St

Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store - Yahoo Finance

5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades - Yahoo Finance

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Emergent BioSolutions Inc. Common Stock - GlobeNewswire Inc.

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 - The Manila Times

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference - The Bakersfield Californian

Emergent BioSolutions (NYSE:EBS) Shares Up 3.2%Here's What Happened - MarketBeat

Biopharma Layoffs Roundup - Contract Pharma

Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata - Yahoo Finance

3 Stocks Poised for Better Returns With New Analyst Coverage - Yahoo Finance

Emergent BioSolutions Inc. (NYSE:EBS) Short Interest Up 84.1% in September - MarketBeat

Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 - Insider Monkey

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus.com

Smallpox Treatment Market to Experience Holistic Expansion - openPR

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ... By GuruFocus - Investing.com Canada

Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says - Yahoo Finance

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic - The Manila Times

Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by AQR Capital Management LLC - MarketBeat

12 Best Performing Cheap Stocks in 2024 - Insider Monkey

Lipid Nanoparticles Market Research 2024 - GlobeNewswire Inc.

Emergent BioSolutions (STU:ER4) EV-to-EBITDA : -3.33 (As of Oct. 06, 2024) - GuruFocus.com

Emergent BioSolutions (STU:ER4) Profitability Rank : 7 (As of Jun. 2024) - GuruFocus.com

Emergent BioSolutions (STU:ER4) Free Cash Flow per Share : €0.69 (TTM As of Jun. 2024) - GuruFocus.com

Renaissance Technologies LLC Trims Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Squarepoint Ops LLC Buys Shares of 231,014 Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Emergent BioSolutions grants CFO equity award By Investing.com - Investing.com Australia

Emergent BioSolutions grants CFO equity award - Investing.com India

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario - citybiz

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario (EBS) - Seeking Alpha

Emergent BioSolutions Grants CFO Stock for Contributions - TipRanks

Marshall Wace LLP Has $3.70 Million Stake in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Emergent BioSolutions secures $100 million credit facility By Investing.com - Investing.com South Africa

What's Going On With Emergent BioSolutions Stock Wednesday? - Benzinga

Emergent BioSolutions Closes $100 Million Financing - citybiz

Emergent Biosolutions Secures Loan, Bolsters Growth Strategy - TipRanks

Emergent BioSolutions secures $100 million credit facility - Investing.com

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility - The Manila Times

Emergent BioSolutions Inc. Announces Closing of $100 Million Asset-Backed Loan Facility - Marketscreener.com

Rhumbline Advisers Sells 69,920 Shares of Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat

Emergent Bio gains after U.S. govt. order for smallpox therapy - MSN

Reviewing Pulmatrix (NASDAQ:PULM) & Emergent BioSolutions (NYSE:EBS) - Defense World

Emergent Biosolutions lays off 300 people - MSN

U.S. secures additional smallpox treatments for $67.4 million - Investing.com

Emergent Bio stock gains after U.S. govt. order (NYSE:EBS) - Seeking Alpha

Emergent Biosolutions Inc (EBS) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EBS과 유사한 종목